Top Markets
#1 Helium Helium +60.93%
#2 GEKKO GEKKO +48.56%
#3 Pons Pons +40.70%
#4 ADO Protocol ADO Protocol +39.08%
#5 Prom Prom +37.33%
#6 TENDIES TENDIES +31.81%
#7 StonkBroker StonkBroker +30.27%
#8 Collector Crypt Collector Crypt +26.66%
#9 Collect on Fanable Collect on Fanable +24.06%
#10 龙虾 (Lobster) 龙虾 (Lobster) +21.13%
Coin of the day
Helium Helium
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Cisen Pharmaceutical Co., Ltd. Cisen Pharmaceutical Co., Ltd.

Cisen Pharmaceutical Co., Ltd.

603367
Classifica tra le azioni #9636
Cisen Pharmaceutical Co., Ltd. operates as a pharmaceutical enterprise,... Cisen Pharmaceutical Co., Ltd. operates as a pharmaceutical enterprise, manufacturing and distributing a diverse portfolio of chemical drug preparations and healthcare products to both domestic and international markets. Founded in 1998 and based in Jining, People's Republic of China, the company offers an extensive range of chemical drug solutions. These include medications for liver diseases, antitumor and supportive treatments, nutritional supplements, contrast agents, antibiotics, digestive system remedies, polypropylene ampoules, and topical preparations. Additionally, their product line encompasses sedation and anesthesia agents, cardiovascular drugs, treatments for cough and asthma, immunomodulators, and various infusion and therapeutic infusion products. The company officially changed its name to Cisen Pharmaceutical Co., Ltd. in 2011, having previously operated as Shandong Lukang Cisen Pharmaceutical Co., Ltd.
Prezzo delle azioni
$2.15
Ultima sincronizzazione: 2026-08-28
Capitalizzazione di mercato
$974.31M
Variazione (1 giorno)
0.41%
Variazione (1 anno)
-39.73%
Paese
CN
Scambia Cisen Pharmaceutical Co., Ltd. (603367)

Categoria

Healthcare
Rapporto P/B per Cisen Pharmaceutical Co., Ltd. (603367)
Rapporto P/B al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Cisen Pharmaceutical Co., Ltd., il rapporto P/B attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/B per Cisen Pharmaceutical Co., Ltd. da 2026 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
Non abbastanza dati per le date fornite.
Rapporto P/B per aziende simili o concorrenti
Azienda Rapporto P/B Differenza del rapporto P/B Il paese
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 5.5207 -
IN